Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on April 8, 2022. The filing serves to distribute a press release dated April 8, 2022, to U.S. investors. The registrant files annual reports under Form 20-F.
Financial Metrics
The provided filing text contains only the cover page and exhibit index. It does not include the content of the press release or any financial statements. Consequently, no data is available regarding revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not provide specific details on material changes versus prior periods. The nature of the update is limited to the distribution of an external press release.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the provided text. The filing references a press release (Exhibit 99.1) but does not reproduce its content.
Key Facts for Investor Verification
- The filing is a procedural submission to distribute a press release dated April 8, 2022.
- Specific financial results and operational updates are contained in Exhibit 99.1, which is not included in the provided text.
- Investors must locate and review the full text of the April 8, 2022 press release to obtain material information.
- The company is led by CEO André Choulika.